AlphAIAlphAI — Financial news for AI agents
yahoo.comAUG 313 min read$USNA

Reflecting On Personal Care Stocks’ Q2 Earnings: USANA (NYSE:USNA)

Nature's Sunshine (NYSE:USNA) reported $117M revenue, up 1.9% YoY, missing estimates. Herbalife (NYSE:HLF) reported $1.33B revenue, up 5.4%, beating estimates. Inter Parfums (NASDAQ:IPAR) reported $341M revenue, up 2.1%, beating estimates. All three stocks declined since earnings.

Original reporting
yahoo.com
Published Aug 31, 2026, 4:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 31, 2026, 5:26 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
Reflecting On Personal Care Stocks’ Q2 Earnings: USANA (NYSE:USNA) — source image
Source · yahoo.com
Decision brief

The 30-second read

$USNANeutralMed
01

Why it matters

Earnings releases drive immediate price moves; mixed results suggest sector‑wide scrutiny.

02

Market read

Provides fresh earnings data for three listed personal‑care firms, useful for short‑term traders.

03

What to watch

Potential cost‑structure issues and competitive pressure not detailed in the article.

Relevance 8/10Novelty 7/10Timing: after‑hours

Background

The article reviews Q2 earnings of three personal‑care companies, noting revenue beats, EPS misses, and stock reactions.

Company-level read

Ticker impact

$USNANeutralLow confidence
Context

Title mentions USANA personal‑care Q2 earnings; article focuses on sector earnings.

Expected impact

No immediate price move indicated.

Evidence & confidence

Only a headline reference, no new numbers disclosed.

$HLFNeutralMedium confidence
Context

Herbalife posted Q2 revenue $1.33 B, beat sales estimates but missed EPS; stock flat after release.

Expected impact

Sideways trading likely.

Evidence & confidence

Revenue beat offsets EPS miss, resulting in flat price.

$IPARBearishMedium confidence
Context

Inter Parfums reported Q2 revenue $341 M, beating expectations; stock down 8.4% after earnings.

Expected impact

Potential further decline if margin concerns persist.

Evidence & confidence

Guidance miss and margin shortfall outweigh revenue beat.

Market effects

Sector

Personal‑care earnings highlight earnings volatility across the sector.

Regional

U.S. personal‑care stocks may see broader reassessment.

Global

Limited to investors tracking consumer‑goods earnings.

Counterpoint

What could challenge this read

Despite earnings misses, some investors may view the price drops as buying opportunities.

Key entities

  • company
    Nature's Sunshine

    Personal‑care supplement maker.

  • company
    Herbalife

    Nutrition and weight‑management products.

  • company
    Inter Parfums

    Fragrance and perfume licensor.

Read at source← All news

Related articles

OCT 20
$IPARMed

INTERPARFUMS, INC. REPORTS 2026 THIRD QUARTER NET SALES 2026 Third Quarter Conference Call Scheduled for November 5, 2026

INTERPARFUMS INC (IPAR) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 FOR IMMEDIATE RELEASE INTERPARFUMS, INC. REPORTS 2026 THIRD QUARTER NET SALES 2026 Third Quarter Conference Call Scheduled for November 5, 2026 New York, New York, October 20, 2026, Interparfums, Inc. (NASDAQ GS: IPAR) (“Interparfums” or the “Company”) today announce

SEC EDGAR 8-K2 min
SEP 25
$IPARMed

Is Interparfums’ (IPAR) New Global Fragrance Deal a Game-Changer?

Interparfums (IPAR) announced a 10-year deal with PUMA to create and distribute fragrances, starting in 2027. The company reported Q2 sales growth of 2% to $341M, but operating income fell 17% to $49M. IPAR has a strong balance sheet with $169.7M in cash and a 18.4% return on invested capital. The stock trades at a forward P/E of 23.64, with 10.80% short interest.

insidermonkey.com3 min
SEP 22
Med

How Softer Half Year Earnings At Interparfums (ENXTPA:ITP) Has Changed Its Investment Story

Interparfums SA reported H1 2026 sales of €414.29M and net income of €65.46M, both down from the prior year. Lower EPS and profit margins raised concerns about demand and cost control. The company's investment narrative is under scrutiny, with near-term focus on brand demand, pricing power, and cost discipline. Revenue and earnings growth are expected in the mid-single digits.

simplywall.st3 min
SEP 15
$HLFHigh

Herbalife (HLF) Bets $250M On Its Own Battered Stock

Herbalife (HLF) announced a $250M share buyback program over three years. Q2 sales rose 5.4% YoY to $1.3B, with Latin America and Asia Pacific leading growth. Adjusted EBITDA was $166.6M, near guidance. However, the company reported a net loss of $26.3M due to debt extinguishment costs, and gross margin slipped to 77.7%. Management narrowed full-year adjusted EBITDA guidance to $670M-$690M, citing FX headwinds. CFO John DeSimone will retire at year-end, with Scott Schaefer taking over in 2027. T

yahoo.com2 min